Blessing Dzingirai
Biographic Data
| ID | 7895652 |
|---|---|
| NAME | Blessing Dzingirai |
| GIVEN NAMES | Blessing |
| FAMILY NAME | Dzingirai |
| SIGNATURE | DZINGIRAI B |
| AFFILIATIONS | University Medical Center Groningen |
| ORCID | 0000-0001-8208-7821 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Cost-Effectiveness of Screening and Treating Chronic Hepatitis C Virus Infection in Zimbabwe
Screening for HCV among high-risk populations followed by treatment using sofosbuvir/velpatasvir is cost effective under the assumptions made in this study
Health-related quality of life in HIV/Aids patients on antiretroviral therapy at a tertiary care facility in Zimbabwe
Health-related quality of life (HRQoL) is a broad concept reflecting a patient's general subjective perception of the effect of an illness or intervention on physical, psychological and social aspects of their daily life. HRQoL among patients infected with HIV has become an important indicator of impact of disease and treatment outcomes. A cross-sectional survey was carried out at Chitungwiza Central Hospital, Zimbabwe, to assess HRQoL in patient…
No prominent works on this page.
Health-related quality of life in HIV/Aids patients on antiretroviral therapy at a tertiary care facility in Zimbabwe
Health-related quality of life (HRQoL) is a broad concept reflecting a patient's general subjective perception of the effect of an illness or intervention on physical, psychological and social aspects of their daily life. HRQoL among patients infected with HIV has become an important indicator of impact of disease and treatment outcomes. A cross-sectional survey was carried out at Chitungwiza Central Hospital, Zimbabwe, to assess HRQoL in patient…
Cost-Effectiveness of Screening and Treating Chronic Hepatitis C Virus Infection in Zimbabwe
Screening for HCV among high-risk populations followed by treatment using sofosbuvir/velpatasvir is cost effective under the assumptions made in this study
Environmental health (2 works) · HIV/AIDS Research and Interventions (2 works) · Medicine (2 works) · Antiretroviral therapy (1 works) · Cost effectiveness (1 works) · Cost-effectiveness analysis (1 works) · Family medicine (1 works) · Health Systems, Economic Evaluations, Quality of Life (1 works) · Hepatitis B Virus Studies (1 works) · Hepatitis C virus (1 works)